Tuesday - February 3, 2026
UCL research leads to new NHS treatment for high-risk prostate cancer
January 15, 2026
LONDON, England, Jan. 15 -- The University College London posted the following news:

* * *

UCL research leads to new NHS treatment for high-risk prostate cancer

*

Men with high-risk locally advanced prostate cancer in England will soon be offered the drug abiraterone on the NHS, following landmark findings from the UCL-led STAMPEDE trial.

NHS England announced today that newly diagnosed men, whose prostate cancer has not spread, w . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products